Detected ·
Altay Therapeutics
$37M—
Altay Therapeutics closed a $37M Series A financing, backed by Fountain Healthcare Partners, to advance its first oral DUX4 inhibitor for FSHD into clinical trials.
- Website
- www.altaytherapeutics.com
- linkedin.com/company/69914567
- Amount
- $37 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-10-14 20:05:23 UTC
- Signal ID
- 67ad6da5-f92e-405a-8cec-87a9d2451c46
As the API returns it
{
"id": "67ad6da5-f92e-405a-8cec-87a9d2451c46",
"created_at": "2026-10-14T20:05:23.086869Z",
"company_name": "Altay Therapeutics",
"company_website_url": "www.altaytherapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/69914567",
"event_type": "funding",
"funding_amount": 37000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Altay Therapeutics closed a $37M Series A financing, backed by Fountain Healthcare Partners, to advance its first oral DUX4 inhibitor for FSHD into clinical trials.*"
}